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Fluorescence in situ hybridization and real-time PCR analysis targeting the 16S rRNA gene of Akkermansia
muciniphila were performed to determine its presence in the human intestinal tract. These techniques revealed
that an A. muciniphila-like bacterium is a common member of the human intestinal tract and that its
colonization starts in early life and develops within a year to a level close to that observed in adults (108 cells/g)
but decreases (P < 0.05) in the elderly.
The human gastrointestinal (GI) tract is colonized by a com-
plex and diverse microbiota that shows different compositions
and activities depending on environmental and genetic factors
(8, 14, 16, 18, 19). The intestinal microbiota starts to establish
at birth and continues to develop and change during life and
also provides a barrier against colonization of pathogens and
harmful substances, protecting intestinal integrity, and stimu-
lates the development of the immune system (10, 14).
A mucus layer covering the GI tract has been reported to
serve as a source of nutrients for bacterial growth (6). Thus, its
presence influences intestinal colonization by attracting bacte-
ria that have the ability to survive and multiply within the
mucus layer. The mucus layer also contributes to host defense
by preventing bacterial adhesion or invasion and toxin binding
to the mucosal surface (11). Nevertheless, the association of
the microbiota with the mucus is not well understood and
requires further investigation.
A novel mucin-degrading bacterium designated Akkerman-
sia muciniphila has been isolated and characterized from a
fecal sample from a healthy adult (6). Subsequent studies
based on 16S rRNA gene cloning and sequencing have dem-
onstrated that A. muciniphila is present in distinct parts of the
human mucosa as well as in fecal samples (7, 9, 17). The
relation between mucin and bacteria varies depending on the
microbiota, and several studies have reported a potential in-
volvement of mucin-degrading bacteria in pathogenesis of in-
testinal diseases (3). Mucosal surfaces, microbiota, and mucus
secretion may be altered due to environmental factors, includ-
ing age. As a consequence, the composition and thickness of
the mucus layer may be modified (4). Such changes may alter
the contact between intestinal microbiota and mucosal den-
dritic cells. As the mucus quality and quantity alter during
ageing, we hypothesized that the levels of intestinal A. muci-
niphila could be different during human life, and detection of
the presence of this bacterium requires detailed investigation.
Fecal samples from healthy infant subjects 1 month old (n
50), 6 months old (n  50), and 12 months old (n  50);
healthy adults from 25 to 35 years old (n  54); and elderly
subjects from 80 to 82 years old (n  45) were collected and
analyzed. Two grams of fresh fecal samples was used and
suspended in 20 ml of phosphate-buffered saline. The suspen-
sion was vortexed thoroughly with 3-m-diameter glass beads
and centrifuged at 800  g for 1 min to remove debris. Dif-
ferent aliquots from the pure culture and fecal samples were
used to extract DNA and to fix cells for fluorescence in situ
hybridization (FISH) analysis. One volume of the supernatant
was transferred into 3 volumes of fresh 4% paraformaldehyde
and fixed at 4°C overnight. The bacteria were stored in 50%
ethanol–phosphate-buffered saline at 20°C until analysis.
One volume was used for DNA extraction by using a QIAamp
DNA stool mini kit (Qiagen, Hilden, Germany), following the
manufacturer’s instructions.
Two specific primers were designed from the variable re-
gions of the 16S rRNA gene sequence of A. muciniphila. The
GenBank program from NCBI (BLAST) was used to verify
that both primers were specific to the target organism only.
The primers selected for detection of A. muciniphila were
named on the basis of nomenclature from Alm et al. (1). These
primers were S-St-Muc-1129-a-a-20 (AM1), with the sequence
5CAG CAC GTG AAG GTG GGG AC, and S-St-Muc-1437-
a-A-20 (AM2), with the sequence 5CCT TGC GGT TGG
CTT CAG AT (Table 1). All primers were purchased from
MWG (Ebersgerg, Germany). To check the specificity of the
amplification, standard PCR amplification was performed, us-
ing as the template DNA from 20 intestinal isolates (Table 2);
96 cloned 16S rRNA genes from uncultured bacteria belonging
to the most dominant groups found in the GI tract, including
Bacteroidetes, Clostridium cluster XIVa, and Clostridium clus-
ter IV; and other clones belonging to disparate clusters, in-
cluding Bifidobacterium, Lactobacillus, and Atopobium (5, 15,
18). The PCR primers were specific for A. muciniphila at 60°C,
with amplification of a product of the expected size (327 bp)
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(data not shown). All other nontargeted strains tested and the
cloned 16S rRNA genes from uncultured GI tract bacteria
showed no amplification during PCR (data not shown).
Quantitative PCR amplification and detection were per-
formed with optical-grade 96-well plates with an ABI PRISM
7300-PCR sequence detection system (Applied Biosystems,
United Kingdom). Each reaction mixture of 25 l was com-
posed of SYBR green PCR master mix (Applied Biosystems,
United Kingdom), 1 l of each of the specific primers at a final
concentration of 0.25 M, and 1 l of template DNA. The
PCR conditions were as follows: 95°C for 5 min, followed by 40
cycles of 95°C for 15 s, 60°C for 40 s, and 72°C for 30 s, and a
final extension at 72°C for 5 min. The fluorescent products
were detected at the last step of each cycle. A melting curve
analysis was made after amplification to distinguish the tar-
geted PCR product from the nontargeted PCR product. Stan-
dard curves were created using serial 10-fold dilutions of A.
muciniphila pure culture DNA corresponding to 102 to 1010
cells as determined by flow cytometry counts. The bacterial
concentration of each sample was calculated by comparing the
threshold cycle (CT) values obtained from the standard curve.
All samples were analyzed in duplicate.
In addition, FISH coupled with flow cytometry (FCM-FISH)
was carried out by following the procedure described in refer-
ence 5, using a specific oligonucleotide probe, MUC-1437 (Ta-
ble 3), targeting one region of the 16S rRNA gene of A.
muciniphila, to compare and validate the method. Total bac-
terial cell numbers were enumerated, using fluorescein-labeled
probe EUB-338 (2, 13) as a positive control and probe Non-
EUB (2, 13) as a negative control, to monitor the nonspecific
hybridizations (Table 3). Absolute bacterial cell counts were
determined by addition of Flow-Count fluorospheres, follow-
ing the supplier’s instructions (Beckman Coulter). Flow-cyto-
metric analyses were performed using a BD LSR II flow cy-
tometer (Becton Dickinson) equipped with a 488-nm laser at
15 mW. Data were stored as list mode files and analyzed offline
using BD FACSDiva version 4.1.1 software (Becton Dickin-
son).
A linear relationship was observed between the cell counts
and CT values (r
2  0.9906) when the number of cells per
reaction mixture was between 102 and 109. Reliable quantifi-
cation of cells was not possible at concentrations below 10 cells
per reaction mixture. This corresponds to a detection limit of
5  102 cells/g feces. Melting curve analysis of the amplicons
obtained by real-time PCR generated a specific peak at 85°C in
the 16S rRNA gene of A. muciniphila. The inter-PCR repro-
ducibility of the quantification was found to be very high based
on the CT values obtained for two DNA extracts (a pure cul-
ture and a fecal specimen harboring approximately 108 to 109
A. muciniphila-like bacteria/g) in five replicate runs. The aver-
age CT values obtained for those samples were 11.0 (range,
10.9 to 11.1) and 11.2 (range, 11.0 to 11.4). Similar results were
observed with other samples and in other dilutions (average
and standard deviation, 11.1  0.5). By analysis of duplicate
DNA extracts from fecal samples, the interextract variability
was found to be less than 10% (data not shown).
Application of the real-time-PCR approach to fecal samples
of infants (up to 1 year old), young adults (25 to 35 years old),
and elderly subjects (80 to 82 years old) showed that A. muci-
niphila-like bacteria appeared in early life and increased sig-
nificantly in number from early life to adult age (Fig. 1 and
TABLE 2. Species and origins of reference strains used for
validation of the Akkermansia muciniphila primers
(AM1 and AM2) and probe (MUC-1437)
Species Originb
Akkermansia muciniphila ...............................................ATCC BAA-835
Atopobium minutuma .....................................................DSM 20586
Bacteroides distasonis......................................................DSM 20701
Bacteroides fragilisa .........................................................DSM 2151
Bacteroides pyogenes .......................................................CCUG 15419
Bacteroides tectus ............................................................CCUG 25929
Bacteroides thetaiotaomicrona ........................................RRI
Bacteroides uniformisa ....................................................DSM 6597
Bifidobacterium lactisa ....................................................DSM 10140
Bifidobacterium bifiduma................................................DSM 20082
Bifidobacterium adolescentisa .........................................DSM 20083
Bifidobacterium brevea ....................................................DSM 20091
Bifidobacterium longuma ................................................DSM 20090
Clostridium aminophilum ...............................................ATCC 49906
Clostridium sticklandii ....................................................ATCC 12662
Clostridium perfringensa ..................................................DSM 756
Clostridium sporogenes ...................................................DSM 1664
Colinsella aerofaciensa ....................................................DSM 3979
Coprococcus sp.a .............................................................RRI
Enterococcus faecalis ......................................................RRI
Escherichia colia ..............................................................NCTC 12900
Eubacterium biforme.......................................................DSM 3989
Eubacterium cylindroides ................................................RRI
Eubacterium rectale.........................................................RRI
Eubacterium ruminantium..............................................RRI
Faecalibacterium prausnitzii ...........................................RRI
Lachnospira multiparus ..................................................RRI
Lactobacillus acidophilusa ..............................................ATCC 4356
Lactobacillus amylovorusa ..............................................DSM 20531
Lactobacillus rhamnosusa...............................................ATCC 53103
Lactobacillus plantaruma................................................NCIMB 8826
Lactobacillus reuteria.......................................................DSM 20016
Megasphaera elsdenii.......................................................NCIMB 8927
Mitsuokella multiacidus ..................................................RRI
Peptostreptococcus anaerobius .......................................ATCC 27337
Pepstostreptococcus micros .............................................DSM 20468
Prevotella albensis............................................................DSM 11370
Prevotella brevis ...............................................................ATCC 19188
Prevotella bryantiia...........................................................DSM 11371
Prevotella ruminocolaa ....................................................ATCC 19189
Roseburia intestinalis.......................................................RRI
Ruminococcus albus........................................................RRI
Ruminococcus bromii .....................................................RRI
Ruminococcus flavefasciens............................................RRI
Ruminococcus hansenii ..................................................DSM 20583
Ruminococcus productus ................................................DSM 2950
Streptococcus bovis..........................................................RRI
Veilonella parvula ............................................................RRI
Victivallis vadensisa .........................................................DSM 14823
a The strains of these species were tested using the AM1 and AM2 primers.
b RRI, Rowett Research Institute (Aberdeen, United Kingdom).
TABLE 1. Primer sequences used in this study
Primer Sequence Nomenclature Annealingtemp (°C) Reference
AM1 CAGCACGTGAA
GGTGGGGAC
S-St-Muc-1129-
a-a-20
50 5
AM2 CCTTGCGGTTG
GCTTCAGAT
S-St-Muc-1437-
a-A-20
50 5
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Table 4). The presence of A. muciniphila-like bacteria was
detected in 8 of the 50 fecal samples of 1-month-old infants
(16% of the samples) at levels from 2.05 to 4.36 log cells/g.
Bacteria related to A. muciniphila were detected in 36 out of 50
children aged 6 months (72% of the samples) and 45 of 50
children at 12 months of age (90% of the samples). The values
ranged from 2.50 to 7.30 log cells/g and 2.80 to 9.50 log cells/g
in samples from 6- and 12-month-old infants, respectively. The
number of bacteria related to A. muciniphila increased signif-
icantly (P  0.05) from early life to adult age and reached
levels ranging from 5.00 to 8.80 log cells/g in all samples from
adults. These data indicate that A. muciniphila-like bacteria
are colonizing the intestinal tract in early life and develop
within a year to a level close to that observed in adults. Re-
markably, the concentrations of A. muciniphila cells in fecal
samples from elderly subjects were significantly decreased (	1
logarithmic unit, to 6.00 log cells/g; P  0.05) compared to
those in samples from adults.
In addition, all fecal samples tested were analyzed also by
FCM-FISH for comparison to the results obtained by quanti-
tative real-time PCR. A good correlation between the results
obtained with the two methods was found (Table 4). Never-
theless, in fecal samples harboring small numbers of A. muci-
niphila-like bacteria, the FCM-FISH approach estimated their
numbers to be about 1 logarithmic unit higher than the real-
time PCR method, probably due to background and/or unspe-
cific signals (Table 4).
The results of the quantitative real-time PCR and FISH-
FCM results showed a good correlation, but differences were
found between these methods in samples with low numbers
(104 cells/g) of bacteria related to A. muciniphila. Similarly,
FCM-FISH and real-time PCR results showed different levels
of A. muciniphila-like bacteria when suspensions of pure cul-
tures with concentrations ranging from 4 to 2 log cells/g were
tested. FCM-FISH tended to detect more A. muciniphila-like
bacteria than real-time PCR. In some cases, FCM-FISH could
lead to an overestimation of the number of A. muciniphila-like
bacteria in fecal samples with low content, due to the forma-
tion of unspecific hybridizations in complex matrices of fecal
samples or to undescribed Akkermansia species that do not
provide an amplification product with the developed primers
targeted to A. muciniphila. In addition, cell hybridizations with
fluorescent probes provide background levels that a flow cy-
tometer may detect as cells, increasing the percentage of cells
detected compared to that of cells obtained by PCR. Thus, the
advantage of this specific PCR technique is that the method is
approximately 10 to 100 times more sensitive and specific than
the culture and FISH methods.
The presence of A. muciniphila-like bacteria was detected in
fecal samples from infants 1 month old, but the number in-
creased rapidly with the age (6- and 12-month-old infants and
adults). The numbers of bacteria related to A. muciniphila
almost doubled in the age period ranging from 6 to 12 months.
These data are in agreement with earlier observations (12)
which reported the establishment of mucin-degrading micro-
biota in children from birth to the age of 2 years, based on agar
gel electrophoresis of their fecal samples. The establishment of
mucin-degrading bacteria was reported during the first months
of life and is completed when the children are around 2 years
old (12). These data indicate that A. muciniphila is colonizing
TABLE 3. Probe sequences and hybridization conditions used in
this study
Probe Sequence Target
Hybridization
conditions
Reference(s)
Temp
(°C)
%
Formamide
EUB-338 GCTGCCTCCC
GTAGGAGT
Most bacteria 50 0 2, 13
NON-EUB ACATCCTACG
GGAGGC
None 50 0 2, 13
MUC-1437 CCTTGCGGTT
GGCTTC
AGAT
Akkermansia 50 20 5
FIG. 1. A. muciniphila levels in human fecal samples as determined
by real-time PCR over a life span. Data represent the positive samples.
The line in the box represents the median (50th percentile), with the
lower line the 25% border (25th percentile) and the upper line the
75% border (75th percentile). The end of the upper vertical line
represents the maximum data value, outliers not considered. The end
of the lower vertical line represents the lowest value, outliers not
considered. The separate dots indicate outliers.
TABLE 4. Numbers of A. muciphila-like bacteria per gram of feces
in fecal samples analyzed by real-time PCR and FCM-FISH
Sample group
No. of
infected
samples/total
no. of
samples
Log no. of cells/g fecesa as
determined by:
Quantitative
PCR FCM-FISH
Infant (1 mo old) 8/50 3.90 (2.25–4.32)c 4.56 (5.06–4.03)c
Infant (6 mo old) 36/50 3.90 (3.52–4.36) 6.50 (5.90–7.40)b
Infant (12 mo old) 45/50 5.20 (4.08–7.00) 7.33 (7.05–7.94)b
Adult 54/54 7.61 (6.02–8.05) 8.10 (7.90–8.32)b
Elderly 43/45 6.00 (4.22–7.66) 7.28 (6.63–7.96)b
a Total bacteria in samples ranged from 9.0 to 10 log cells/g of fecal samples.
Due to nonnormal distribution, microbial data are expressed as medians, with
interquartile ranges in parentheses. The Mann-Whitney U test was applied in
comparisons among groups.
b Significant differences (P  0.05) were determined by a Mann-Whitney test
comparing qPCR and FCM-FISH data.
c All data from different age groups were significantly different (P 0.05), with
only one exception: data from 1-month-old and 6-month-old infants.
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the intestinal tract in early life and develops within a year to a
level close to that observed in adults (Fig. 1). Akkermansia was
detected in all samples from adults at levels ranging from 5.00
to 8.80 log cells/g, and this is in agreement with early data (5).
Our results suggest that the possible rise in concentrations of
bacteria is related to A. muciniphila along with normal mucosa
development. This rise may be associated with the integrity of
the developing healthy intestinal tract with normal mucus pro-
duction. However, the numbers of A. muciniphila-like bacteria
in elderly subjects (80 to 82 years old) were significantly de-
creased (1 logarithmic unit; P  0.05) compared to those in
young and middle-aged adults. Although it cannot be ruled out
that these bacteria do not show a dependency on mucin as a
carbon and nitrogen source similar to that of A. muciniphila, it
is likely that this reflects the coevolution of specific mucin-
degrading bacteria and mucus production.
Taken together, the techniques described here are accurate,
rapid, and easy methods for quantification of A. muciniphila in
human feces. These methods will facilitate rapid and reliable
counting of large numbers of samples, contributing to the ef-
ficient use of intestinal bacterial assays in research as well as in
the assessment of dietary management of diseases. We also
demonstrate for the first time the validation and development
of a quantitative real-time PCR for detection and quantifica-
tion of bacteria related to the mucin-degrading bacterium A.
muciniphila. Our results demonstrate that A. muciniphila is
present and colonizes the intestinal tract in early life and de-
velops within a year to a level close to that observed in healthy
adults. Further studies are needed to clarify the role of A.
muciniphila in microbiota development and immune develop-
ment in early childhood and old age.
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